 | Savara, Inc. | |||
| NMS : SVRA || Location: United States | ||||
$4.24-0.45 (-9.59%) |
1.0 M | 4.24 - 4.72 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.704 M |
| March 15, 2024 | 3.401 M |
| Feb. 29, 2024 | 2.891 M |
| Feb. 15, 2024 | 2.716 M |
| Jan. 31, 2024 | 2.891 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.11 | -0.09 | 14.85% |
| 09/30/2023 | -0.07 | -0.10 | -36.24% |
| 06/30/2023 | -0.08 | -0.07 | 11.50% |
| 03/31/2023 | -0.07 | -0.07 | 1.96% |
| 12/31/2022 | -0.07 | -0.07 | 5.41% |
SVRA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 138.148M | Shares Float | 81.340M |
| Short Float | 3.704M | Market Cap | 647.91M |
| Institution ownership | 81.26% | Insider ownership | 6.167% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.33 | Forward EPS | -0.34 |